Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Inflammation × Dexmedetomidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 10 Brain Neoplasms 7 Breast Neoplasms 4 Agnosia 4 Thyroid Neoplasms 3 Emergence Delirium 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Lung Neoplasms 2 Dexmedetomidine 2 Colorectal Neoplasms 2 Chronic Pain 2 Thrombosis 1 Supratentorial Neoplasms 1 Sigmoid Neoplasms 1 Sedation 1 Sarcoma 1 Retinoblastoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Postoperative Nausea and Vomiting 1 Pheochromocytoma 1 Pain 1 Neoplasms 1 Morphine Consumption 1 Lung Injury 1 Inflammation 1 Hyperthyroidism 1 Hyperparathyroidism 1

Interventions

Resistance Training 2 Exercise 2 falcarinol 1 falcarindiol 1 Tea 1 Selenium 1 Saline Solution 1 Reperfusion 1 Qigong 1 Probiotics 1 Platelet Count 1 Plastic Surgery Procedures 1 Nutrition Assessment 1 Mindfulness 1 Metformin 1 Massage 1 Ischemic Preconditioning 1 Inositol 1 Ibuprofen 1 Hyperspectral Imaging 1 High-Intensity Interval Training 1 Folic Acid 1 Fish Oils 1 Dexmedetomidine 1 Colchicine 1 Cognitive Behavioral Therapy 1 Chromatin Immunoprecipitation Sequencing 1 Aspirin 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06993740 2025-06-15

DEXFLAP

Dharmais National Cancer Center Hospital

Phase NA Recruiting

Inflammation, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡